Health Condition 1: K029- Dental caries, unspecified
Conditions
Interventions
Intervention1: transmucosal dexmedetomidine
as a preanesthetic medication: transmucosal dexmedetomidine-It is a selective alpha 2 agonist.
1microgram/kg will be given as premedication to children aged
Sponsors
DrHarshita Gosavi
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA physical status I (A normal healthy patient) and II (A patient with mild systemic disease) 2.Patients electively posted for dental procedures under general anaesthesia 3.Children with Frankel’s behavior rating of 1 (Definitely Negative) & 2 (Negative)
Exclusion criteria
Exclusion criteria: 1.Parents/Guardians who refuse to allow participation in the study. 2.Patients with any underlying systemic diseases. 3.Patients allergic to the drugs involved in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Transmucosal Dexmedetomidine as a premedication is effective in decreasing sedation, parental separation anxiety, & increasing mask acceptance in comparison to transmucosal Midazolam. 2)Transmucosal Dexmedetomidine has higher efficacy of decreasing postoperative emergence delirium than Midazolam. Timepoint: Immediate postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) transmucosal route is an effective way for delivery of preanesthetic medication in childrenTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactDrHarshita Gosavi
RUHS College of Dental Sciences,Jaipur
Outcome results
None listed